Nordic healthcare authorities want to negotiate shared deal over Bluebird Bio's gene therapy

Denmark, Sweden, Norway, Finland and Iceland will collectively negotiate with a pharmaceutical company over the price of a treatment for the first time.

Photo: Bluebird Bio/ PR

Log in to read our articles

Welcome to MedWatch. A part of our content is exclusive and reserved for our users.

Try MedWatch for 14 days.

Get a trial subscription here.

Do you want a trial subscription with multiple users for yourself and your colleagues?

Read more about your options and find the contact information to our sales team here.

Related articles